The AF Association – Healthcare Pioneers Report 2018 includes 38 articles describing ways of finding patients with undiagnosed AF using, for example smartphones or simple pulse checks, methods to ensure that adequate assessment is undertaken to define underlying causes and potential complications, treatment techniques involving antiarrhythmic drugs to suppress the development of AF, anticoagulant drug therapy to prevent AF-related stroke, left atrial ablation (a technique to try and prevent further attacks of AF), and more.
This document is a framework service specification for the delivery of anticoagulation services for people with atrial fibrillation (AF). The specification was developed by Anticoagulation UK in close collaboration with experts in anticoagulation from across primary, community and secondary care. The standards within this framework reflect best practice for services to adhere to, both during and beyond the COVID-19 pandemic. This project has been fully funded by Bayer plc. The content is independent of and not influenced by Bayer plc who checked the final document for technical accuracy only.